CSIMarket Company Name, Ticker, Competitors, else..


Ligand Pharmaceuticals Inc  (NASDAQ: LGND)
Other Ticker:  
 

Ligand Pharmaceuticals Inc

LGND's Fundamental analysis



Looking into Ligand Pharmaceuticals Inc growth rates, revenue grew by 29.66 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 2068

Major Pharmaceutical Preparations industry recorded growth of revenues by 12 %

Ligand Pharmaceuticals Inc net loss increased from $-10 millions, to $-31 millions in IV. Quarter 2024,

• More on LGND's Growth


Ligand Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 40.16 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.86.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.


• More on LGND's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 827,391
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.82
 Tangible Book Value (Per Share $) 25.02

Ligand Pharmaceuticals Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 40.16 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.86.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.

Ligand Pharmaceuticals Inc Price to Book Ratio is at 2.39 lower than Industry Avg. of 91.98. and higher than S&P 500 Avg. of 0.01

• More on LGND's Valuation

•  Market Capitalization (Millions $) 1,982
•  Shares Outstanding (Millions) 18
•  Employees 202
•  Revenues (TTM) (Millions $) 167
•  Net Income (TTM) (Millions $) -4
•  Cash Flow (TTM) (Millions $) 49
•  Capital Exp. (TTM) (Millions $) -2
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 827,391
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4.82
•  Tangible Book Value (Per Share $) 25.02

•  Market Capitalization (Millions $) 1,982
•  Shares Outstanding (Millions) 18
•  Employees 202
•  Revenues (TTM) (Millions $) 167
•  Net Income (TTM) (Millions $) -4
•  Cash Flow (TTM) (Millions $) 49
•  Capital Exp. (TTM) (Millions $) -2





  Ratio
•   Capital Ratio (MRQ) 8.93
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.24
•  Asset Turnover Ratio (TTM) 0.18
•  Inventory Turnover Ratio (TTM) 1.86





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com